What is the recommended algorithm for discontinuing sertraline (Selective Serotonin Reuptake Inhibitor - SSRI)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 29, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Sertraline Discontinuation Algorithm

Sertraline should be gradually tapered over a period of 10-14 days to minimize withdrawal symptoms, with slower tapering needed for patients on higher doses or longer treatment durations. 1, 2

Rationale for Gradual Tapering

Abrupt discontinuation of sertraline can lead to significant withdrawal symptoms due to its relatively short half-life compared to other SSRIs like fluoxetine. These symptoms can include:

  • Somatic symptoms: Dizziness, light-headedness, nausea, vomiting, fatigue, myalgia, flu-like symptoms, sensory disturbances, and sleep disturbances 2
  • Psychological symptoms: Anxiety, agitation, crying spells, and irritability 2
  • Cardiovascular effects: Orthostatic hypotension has been reported with sertraline withdrawal 3

Recommended Tapering Protocol

Standard Tapering Schedule

  1. For patients on 50mg daily (standard dose):

    • Week 1: Reduce to 25mg daily
    • Week 2: Reduce to 25mg every other day
    • Week 3: Discontinue completely
  2. For patients on 100mg daily:

    • Week 1: Reduce to 75mg daily
    • Week 2: Reduce to 50mg daily
    • Week 3: Reduce to 25mg daily
    • Week 4: Reduce to 25mg every other day
    • Week 5: Discontinue completely
  3. For patients on 150-200mg daily:

    • Use smaller decrements (25-50mg) at 1-2 week intervals
    • Extend the tapering period to 6-8 weeks or longer

Special Considerations

  • Long-term users (>1 year): Consider more gradual tapering with smaller decrements and longer intervals between dose reductions 2
  • Elderly patients: Start with lower doses and taper more gradually due to increased risk of side effects 1
  • History of withdrawal symptoms: Use a more extended tapering schedule with smaller decrements

Monitoring During Discontinuation

  1. Regular assessment for emergence of withdrawal symptoms
  2. If severe symptoms occur: Return to the previous dose and slow the rate of taper 2
  3. Monitor for depression relapse: Patients who discontinue antidepressants have a significantly higher risk of relapse (56% vs 39% for those who continue) 4

Managing Withdrawal Symptoms

  • Mild symptoms: Reassurance that symptoms are usually transient 2
  • Moderate symptoms: Slow the rate of taper further
  • Severe symptoms: Return to the previous effective dose and restart tapering at a slower rate 2

Important Cautions

  • Adherence challenges: Only 52% of patients successfully adhere to discontinuation protocols 4
  • Misdiagnosis risk: Withdrawal symptoms may be mistaken for physical illness or depression relapse 2
  • Relapse risk: Patients should be informed about the increased risk of depression relapse after discontinuation 4

Special Populations

  • Adolescents: Follow the same gradual tapering principles, but start from lower doses (typically 25-50mg) 5
  • Patients with cardiovascular issues: Monitor for orthostatic hypotension during the tapering process 3

Remember that withdrawal symptoms are generally mild and self-limiting but can be distressing enough to impact daily functioning. The key to successful discontinuation is a gradual, patient-specific approach with appropriate monitoring and support.

References

Guideline

Serotonin Reuptake Inhibitors and Cardiac Effects

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Clinical management of antidepressant discontinuation.

The Journal of clinical psychiatry, 1997

Research

Maintenance or Discontinuation of Antidepressants in Primary Care.

The New England journal of medicine, 2021

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.